PTC THERAPEUTICS, INC. (PTCT)
Health Care / Pharmaceuticals
S&P SmallCap 600$83.35
Scores poorly across most models. Proceed with caution.
Weak
Score based on 4 of 5 models — moderate confidence
Is PTC THERAPEUTICS, INC. a Good Investment in 2026?
PTC THERAPEUTICS, INC. (PTCT) scores 3.5 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model is the most favorable, rating PTC THERAPEUTICS, INC. as Neutral. However, the Greenblatt Magic Formula model rates it Caution — Bottom half (rank 99%). PTC THERAPEUTICS, INC. ranks #937 out of 1121 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Valuation
Trades at 11x earnings — near sector median of 27x.
Fair value estimate not available for this stock.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Neutral
3/9
Buffett
Caution
Business quality & competitive moat
Graham
Neutral
Price vs intrinsic value
Lynch
Limited Data
Growth rate vs price (PEG)
Greenblatt
Caution
Bottom half (rank 99%)
Frequently Asked Questions
Is PTC THERAPEUTICS, INC. (PTCT) a good investment?
What is PTC THERAPEUTICS, INC.'s Piotroski F-Score?
Is PTCT overvalued or undervalued?
How does PTCT compare to other Health Care stocks?
What do investment models say about PTCT?
Similar Stocks
Compare PTCT with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer